Effect of bethanechol on xerostomia

Phase 2

• Conditions: Cancer of larynx, Hypopharynx, Nasopharynx.; Malignant neoplasm of larynx, Malignant neoplasm of hypopharynx, Malignant of nasopharynx; c11?c13?c3

• Registration Number: IRCT2014061813167N3
• Lead Sponsor: Shahid Sadoughi University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Patients with cancers of head and neck region include progressive larynx cancer, progressive hypopharynx cancer and nasopharynx cancer; undergone radiation with 5000 centigray by linear accelerator; using oral protective shield
Exclusion criteria: Cardiovascular diseases; gastrointestinal diseases

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
nstimulated whole saliva. Timepoint: 2, 4 and 6 weeks after initiation of radiotherapy. Method of measurement: With mililiter by graduated measuring tube by spitting method.